Llorens Josep's Form 4 filing
Haemonetics Corp (HAE) · filed May 21, 2024
- Accession no.
- 0001127602-24-016169
- Filed
- May 21, 2024
- Trade date
- May 17-20, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $171.8K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Llorens JosepCIK 0001750812 | Officer (EVP, Global Manufacturing) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 17, 2024 | Common Stock | SSaleDisposed | −822 | $94.82 | −$77,942.04 | 16,350 | Direct | |
| May 17, 2024 | Common Stock | FTax withholdingDisposed | −320 | $95.73 | −$30,633.6 | 16,030 | Direct | |
| May 17, 2024 | Common Stock | AGrant or awardAcquired | +6,267 | – | – | 22,297 | Direct | |
| May 20, 2024 | Common Stock | SSaleDisposed | −987 | $95.08 | −$93,843.96 | 21,310 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.